The head of Council for Citizens Against Government Waste (CCAGW)—the lobbying arm of a watchdog group which has long advocated [...] …
Year: 2024
Exclusive
Welch Likely to Introduce Senate Version of Matsui’s 340B PATIENTS Act As Soon As Next Week
A Vermont Democrat and longtime 340B advocate is expected to soon introduce a Senate version of the 340B Pharmaceutical Access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
November will bring an epic battle for both the U.S. presidency and control in Congress, both of which could have [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Join Ravin Consultants for an insightful webinar on the ever-changing 340B landscape. We will explore the latest contract pharmacy restrictions and state responses as well as mitigation strategies and alternative distribution models. In addition to getting an update on the latest developments from
…
The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Tell us some interesting details about your company’s history.
RxParadigm, founded in 2021 by CEO Mesfin Tegenu, is built on nearly 30 years of industry expertise, delivering innovative pharmacy
…
SPONSORED CONTENT
TIP: Maintain an accurate and comprehensive provider list to maximize 340B program effectiveness and compliance.
An outdated
The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...] …
